The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Patient’s Journey with Rheumatoid Arthritis Redefines ‘Treat to Target’

Patient’s Journey with Rheumatoid Arthritis Redefines ‘Treat to Target’

March 1, 2015 • By Gretchen Henkel

  • Tweet
  • Email
Print-Friendly Version / Save PDF
John Reigstad
John Reigstad’s goal when starting treatment: “I want to get back to world-class tournament racquetball.” He achieved his goal, placing fourth in the U.S. Open Racquetball Championships in the men’s 60–64-year-old division in 2011.

Like many rheumatologists who treat patients with rheumatoid arthritis, Richard Brasington, MD, professor in the division of rheumatology at the Washington University School of Medicine in St. Louis, knows that patients do better over the long term when they are vested in their care. Still, when he asked a new patient in March 2009 what he wanted to gain from treatment for RA, he was surprised by John Reigstad’s answer: “I want to get back to world-class tournament racquetball.”

You Might Also Like
  • Treat to Target: Rheumatoid Arthritis in Pregnant Patients
  • Treat Rheumatoid Arthritis to Target
  • More Data for Treat to Target: Post-Hoc Analysis of Large RA Clinical Trials Supports Treat-to-Target Recommendations
Explore This Issue
March 2015
Also By This Author
  • Early Fall 2022’s Awards, Appointments & Announcements in Rheumatology

“That wasn’t what I was expecting to hear,” Dr. Brasington now recalls. “What was striking was that the patient was asking for something that I thought probably was not achievable.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

It turns out that Dr. Brasington’s initial assessment of his patient’s goals was premature, because in John Reigstad he encountered an exceptional individual determined to remain active in the face of his rheumatoid arthritis and willing to be a full partner in the physician–patient relationship.

The Acute Phase

Reigstad’s symptoms had first appeared about six months earlier, in October 2008. As a champion racquetball player (Note: He won a world championship tournament in the men’s 55–59-year-old division in 2005), he was weight training for another competition when he injured his shoulder. At first, he attributed the event to incorrect positioning during a set of shoulder presses. But soon, his hands swelled and his body began to ache, and he realized something serious was going on. He remembers, “Trying to grip my racquet produced excruciating pain.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Even at this stage, Reigstad employed remarkable coping strategies for dealing with the painful onset of his disease. As he became progressively weaker and unable to work out, exercise, lift weights or play racquetball, he joined the Botanical Gardens of St. Louis for daily walks and reprised his avocation as a nature photographer.

“Champions keep playing until they get it right.”

—Billie Jean King

Finding the Right Combination

Reigstad first consulted his internist, who prescribed ibuprofen and acetaminophen, and eventually referred him to a rheumatologist. That physician started Reigstad on prednisone. But he was “never comfortable” taking the steroid and reports he didn’t get much relief. “About that time, I also developed frozen shoulder syndrome, so severe I could not thread my belt loops with my pants on. I full-dosed with ibuprofen and acetaminophen around the clock for six months with no feeling of progress. I kept searching for answers.” A racquetball opponent suggested Reigstad see the orthopedist that had done his shoulder replacement. After multiple cortisone injections, Reigstad’s shoulders improved, but his other symptoms had not.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Rheumatoid Arthritis Tagged With: Brasington, Henkel, outcome, patient, physician, Reigstad, Rheumatoid arthritis, rheumatology, TreatmentIssue: March 2015

You Might Also Like:
  • Treat to Target: Rheumatoid Arthritis in Pregnant Patients
  • Treat Rheumatoid Arthritis to Target
  • More Data for Treat to Target: Post-Hoc Analysis of Large RA Clinical Trials Supports Treat-to-Target Recommendations
  • Mortality Rates Improve for Patients with Rheumatoid Arthritis

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)